El Salón de Grados de la Facultad de Ciencias de la Salud de la Universidad Rey Juan Carlos acogerá los días 29-30 de octubre el Metabolic disorders and translational research symposium.

Este symposium reunirá a diferentes ponentes expertos en el estudio de la obesidad, la diabetes y el metabolismo. 

Organizado por las Dras. Patricia Corrales Cordón y Gema Medina-Gomez, coordinadora del Consorcio MOIR - ACTOME,  el symposiu, abordó las causas moleculares de la resistencia a la insulina (RI), las enfermedades asociadas como la obesidad, la diabetes tipo 2 y el síndrome metabólico.

El segundo día de Symposium estará destinado a presentar los avances en el proyecto MOIR-ACTOME.

El programa para los dos días es el siguiente:

 

Day 1 – 29th October, Thursday

08:30-09:00 Arrival and registration.

09:00-09:05 Welcome.

09:05-09:45 Soeren Nielsen. Copenhagen University (Denmark)

A structural niche for human adipose tissue expansion.

09:45-10:20 Rubén Nogueiras. Santiago de Compostela University (Spain)

Tanycytes and metabolic regulation.

10:20-11:00 Claudia González Cucharero. Ramón y Cajal Hospital – University Francisco de Vitoria (Spain)

Translational research in tricuspid regurgitation: metabolic aterations underlying cardiac remodeling?

11:00-11:40 Coffee break

11:40-12:20 Rubén Cereijo. Barcelona University (Spain)

Adipometabolic alterations in antiretroviral-treated people with HIV: lessons from (and for) obesity research.

12:20-13:00 Siegfried Usssar. Helmholtz Münich (Germany)

Removing the brakes on energy expenditure: from human variation to therapeutic opportunity.

13:00-14:00 Lunch

14:00-14:40 Alexander Banks. Beth Israel Deaconess Medical Center and Harvard Medical School (USA)

The future of energy balance research.

14:40-15:20 Thomas Svava Nielsen. Sable Systems Europe GmbH (Germany)

Beyond the rectal probe: convergence of mouse metabolic phenotyping and welfare assessment with continuous body temperature monitoring.

15:20-16:00 Guillermo Sánchez. Granada University (Spain)

Metabolic adaptations to dual GIP/GLP-1 receptor agonism: from preclinical models to clinical evidence.

16:00-16:30 Conclusions and remarks.

 

Day 2 – 30th October, Friday

08:30-09:00 Arrival and registration.

09:00-09:10 Gema Medina Gómez. LIPOBETA. Rey Juan Carlos University (Spain)

Welcome MOIR.

09:10-09:40 Patricia Rada Llano. HEPIR. Institute for Biomedical Research Sols-Morreale (IIBM), CSIC-UAM (Spain)/Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM).

A hypothalamus-liver-skeletal muscle axis controlled by JNK1 and FGF21 mediates olanzapine-induced insulin resistance in an intraperitoneal treatment in male mice.

09:40-10:10 Antonia García. METABOALL. Center for Metabolomics and Bioanalysis, CEU San Pablo University (Spain)

Liver 360°: Development of an Analytical Methodology for the Integration of (Targeted/Untargeted) Metabolomics–Lipidomics in Obesity and Metabolic.

10:10-10:40 Invitation: Ana B. Crujeiras. Santiago Health Research Institute (IDIS/SERGAS) (Spain)

Obesity through the epigenetic lens: From molecular memory to biological aging, cancer and treatment response.

10:40-11:30 Coffee break.

11:30-12:00 Laura Casablanca. DIABEHEART. National Center for Biotechnology (CNB-CSIC) (Spain)

Retinoid X Receptors as Transcriptional Regulators of Metabolic and Immune Functions in Liver Macrophages.

12:00-12:30 Elisa Fernández-Millán. ENTEROBETA. Complutense University of Madrid (Spain)

Gallic acid supplementation preserves pancreatic islet function and improves insulin sensitivity via white adipose tissue–pancreas crosstalk in high-fat diet-fed rats.

12:30-13:00 Invitation: Rubén García. National Center for Biotechnology (CNB-CSIC) (Spain)

Adipocyte extracellular vesicle-associated DNA is a bioactive mediator of obesity-related inflammation.

13:00-14:30 Lunch.

14:30-15:00 Héctor Cañeque Rufo. GESTOBES. CEU San Pablo University (Spain)

Pleiotrophin: a new factor in neurodegenerative disorders associated with metabolicsyndrome.

15:00-15:30 Rocío Vila Bedmar. LIPOBETA. Rey Juan Carlos University (Spain)

Molecular signatures of obesity-associated chronic kidney disease: adipocytokines and miRNAs as Novel Biomarkers.

15:30-16:00 Invitation: María Galán Arroyo. Rey Juan Carlos University (Spain)

Deleterious effects of metabolic disorders on cardiovascular system.

16:00-16:30 Conclusions and remarks.

 

Si estás interesado en asistir, por favor no olvides inscribirte a través del siguiente enlace (inscripciones hasta el 26 de octubre de 2026):

https://forms.cloud.microsoft/e/ZyCkVw221j